BioPorto Diagnostics will be exhibiting at the upcoming International17th Annual congress of the Indian Society of Critical Care Medicine (ISCCM) and International Critical Care Congress 2011. The exhibition will be a joint venture with CPC Diagnostics and Shanti Medical, BioPorto's distributors in India.
Aimed at strengthing the existing bond between industry and the physician community and exploring means to provide affordable medical care to deserving patients, CRITICARE 2011 is one of the most important events on the calendar of every critical care practitioner in India. Around 3,000 Intensivists, Physicians, Pulmonologist, Paediatricians and Anaesthesiologist delegates from India and neighboring countries are expected to take part in this congress.
At the congress, BioPorto Diagnostics will promote The NGAL Test™. Using only a few drops of blood or urine, The NGAL Test™, provides results in just 10 minutes and thus addresses the widespread demand for urgent NGAL determination. The NGAL Test™ is a particle enhanced turbidimetric assay and is designed to run as a user defined reagent on analyzers from Roche, Abbott, Siemens, Olympus and many other manufacturers, effectively giving almost any laboratory access to a fast and easy method to measure NGAL.
Ishan Gupta, Business Development Manager, Sales email@example.com will represent BioPorto Diagnostics. Visit our booth no. 55 in the Vigyan Bhawan Conference Center.